5-Lipoxygenase: Regulation and possible involvement in atherosclerosis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ross, 1999, Atherosclerosis is an inflammatory disease, Am Heart J, 138, S419, 10.1016/S0002-8703(99)70266-8
Steinberg, 2002, Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime, Nat Med, 8, 1211, 10.1038/nm1102-1211
Hansson, 2001, Immune mechanisms in atherosclerosis, Arterioscler Thromb Vasc Biol, 21, 1876, 10.1161/hq1201.100220
Gillmor SA, Villasenor A, Fletterick R, Sigal E, Browner MF. The structure of mammalian 15-lipoxygenase reveals similarity to the lipases and the determinants of substrate specificity. Nat Struct Biol 1997;4:1003–9 [published erratum appears in Nat Struct Biol 1998;5(3):242].
Peters-Golden, 2001, Intracellular compartmentalization of leukotriene synthesis: unexpected nuclear secrets, FEBS Lett, 487, 323, 10.1016/S0014-5793(00)02374-7
Bach, 1974, In vivo and in vitro production of a slow reacting substance in the rat upon treatment with calcium ionophores, J Immunol, 113, 2040, 10.4049/jimmunol.113.6.2040
Borgeat, 1979, Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187, Proc Natl Acad Sci USA, 76, 2148, 10.1073/pnas.76.5.2148
Jakschik, 1980, Calcium stimulation of a novel lipoxygenase, Biochem Biophys Res Commun, 95, 103, 10.1016/0006-291X(80)90710-X
Aharony, 1986, Kinetic mechanism of guinea pig neutrophil 5-lipoxygenase, J Biol Chem, 261, 11512, 10.1016/S0021-9258(18)67273-4
Rouzer, 1985, On the nature of the 5-lipoxygenase reaction in human leukocytes: enzyme purification and requirement for multiple stimulatory factors, Proc Natl Acad Sci USA, 82, 6040, 10.1073/pnas.82.18.6040
Shimizu, 1986, Characterization of leukotriene A4 synthase from murine mast cells: evidence for its identity to arachidonate 5-lipoxygenase, Proc Natl Acad Sci USA, 83, 4175, 10.1073/pnas.83.12.4175
Skorey, 1998, Calcium is not required for 5-lipoxygenase activity at high phosphatidyl choline vesicle concentrations, Biochemistry, 37, 8027, 10.1021/bi980371g
Reddy, 2000, Mg2+ activates 5-lipoxygenase in vitro: dependency on concentrations of phosphatidylcholine and arachidonic acid, Biochemistry, 39, 1840, 10.1021/bi9919246
Percival, 1992, Investigation of the mechanism of nonturnover-dependent inactivation of purified human 5-lipoxygenase—inactivation by H2O2 and inhibition by metal ions, Eur J Biochem, 210, 109, 10.1111/j.1432-1033.1992.tb17397.x
Noguchi, 1994, Human 5-lipoxygenase associates with phosphatidylcholine liposomes and modulates LTA(4) synthetase activity, Bba-Lipid Lipid Metab, 1215, 300, 10.1016/0005-2760(94)90057-4
Hammarberg, 2000, The N-terminal domain of 5-lipoxygenase binds calcium and mediates calcium stimulation of enzyme activity, J Biol Chem, 275, 38787, 10.1074/jbc.M006136200
Kulkarni, 2002, Molecular basis of the specific subcellular localization of the C2-like domain of 5-lipoxygenase, J Biol Chem, 277, 13167, 10.1074/jbc.M112393200
Schatz-Munding, 1991, The involvement of extracellular calcium in the formation of 5-lipoxygenase metabolites by human polymorphonuclear leukocytes, Eur J Biochem, 197, 487, 10.1111/j.1432-1033.1991.tb15936.x
Bürkert, 2003, The C2-like beta-barrel domain mediates the Ca2+-dependent resistance of 5-lipoxygenase activity against inhibition by glutathione peroxidase-1, J Biol Chem, 278, 42846, 10.1074/jbc.M302471200
Sailer, 1998, Characterization of an acetyl-11-keto-beta-boswellic acid and arachidonate-regulatory site of 5-lipoxygenase using photoaffinity labeling, Eur J Biochem, 256, 364, 10.1046/j.1432-1327.1998.2560364.x
Nalefski, 1996, The C2 domain calcium-binding motif: structural and functional diversity, Protein Sci, 5, 2375, 10.1002/pro.5560051201
Rizo, 1998, C2-domains, structure and function of a universal Ca2+-binding domain, J Biol Chem, 273, 15879, 10.1074/jbc.273.26.15879
Rouzer, 1985, On the nature of the 5-lipoxygenase reaction in human leukocytes: characterization of a membrane-associated stimulatory factor, Proc Natl Acad Sci USA, 82, 7505, 10.1073/pnas.82.22.7505
Goetze, 1985, Purification of a mammalian 5-lipoxygenase from rat basophilic leukemia cells, Prostaglandins, 29, 689, 10.1016/0090-6980(85)90130-3
Hogaboom, 1986, Purification, characterization, and structural properties of a single protein from rat basophilic leukemia (RBL-1) cells possessing 5-lipoxygenase and leukotriene A4 synthetase activities, Mol Pharmacol, 30, 510
Puustinen, 1988, Regulation of the human leukocyte 5-lipoxygenase: stimulation by micromolar Ca2+ levels and phosphatidylcholine vesicles, Biochim Biophys Acta, 960, 261, 10.1016/0005-2760(88)90033-1
Riendeau, 1993, Interfacial catalysis and production of a high ratio of leukotriene-A(4) to 5-HPETE by 5-lipoxygenase in a coupled assay with phospholipase-A(2), J Lipid Mediator, 6, 23
Noguchi, 1994, Interfacial kinetic reaction of human 5-lipoxygenase, Eur J Biochem, 222, 285, 10.1111/j.1432-1033.1994.tb18867.x
Chen, 2001, The N-terminal “beta-barrel” domain of 5-lipoxygenase is essential for nuclear membrane translocation, J Biol Chem, 276, 811, 10.1074/jbc.M008203200
Pande, 2004, Modulation of human 5-lipoxygenase activity by membrane lipids, Biochemistry, 43, 14653, 10.1021/bi048775y
Pande, 2005, Membrane fluidity is a key modulator of membrane binding, insertion, and activity of 5-lipoxygenase, Biophys J, 88, 4084, 10.1529/biophysj.104.056788
Qiu, 1998, The role of calcium and phosphorylation of cytosolic phospholipase A(2) in regulating arachidonic acid release in macrophages, J Biol Chem, 273, 8203, 10.1074/jbc.273.14.8203
Gijon, 1999, Role of phosphorylation sites and the C2 domain in regulation of cytosolic phospholipase A2, J Cell Biol, 145, 1219, 10.1083/jcb.145.6.1219
Walther, 2002, The N-terminal domain of the reticulocyte-type 15-lipoxygenase is not essential for enzymatic activity but contains determinants for membrane binding, J Biol Chem, 277, 27360, 10.1074/jbc.M203234200
Hornig, 2005, 1-Oleoyl-2-acetylglycerol stimulates 5-lipoxygenase activity via a putative (phospho)lipid-binding site within the N-terminal C2-like domain, J Biol Chem, 280, 26913, 10.1074/jbc.M500068200
Werz, 2000, 5-Lipoxygenase is phosphorylated by p38 kinase dependent MAPKAP kinases, Proc Natl Acad Sci, 97, 5261, 10.1073/pnas.050588997
Werz, 2002, Extracellular signal-regulated kinases phosphorylate 5-lipoxygenase and stimulate 5-lipoxygenase product formation in leukocytes, FASEB J, 16, 1441, 10.1096/fj.01-0909fje
Luo, 2004, Protein kinase A inhibits leukotriene synthesis by phosphorylation of 5-lipoxygenase on serine 523, J Biol Chem, 279, 41512, 10.1074/jbc.M312568200
Peters-Golden, 1991, Basal activation of protein kinase C in rat alveolar macrophages: implications for arachidonate metabolism, Am J Physiol, 261, L462
Lepley, 1996, Tyrosine kinase activity modulates catalysis and translocation of cellular 5-lipoxygenase, J Biol Chem, 271, 6179, 10.1074/jbc.271.11.6179
Lepley, 1996, Inhibition of mitogen-activated protein kinase kinase blocks activation and redistribution of 5-lipoxygenase in HL-60 cells, Arch Biochem Biophys, 331, 141, 10.1006/abbi.1996.0292
Lee, 2000, Inhibition of p38 MAP kinase as a therapeutic strategy, Immunopharmacology, 47, 185, 10.1016/S0162-3109(00)00206-X
Werz, 2001, p38 MAP kinase mediates stress-induced leukotriene synthesis in a human B-lymphocyte cell line, J Leuk Biol, 70, 830, 10.1189/jlb.70.5.830
Werz, 2002, Arachidonic acid promotes phosphorylation of 5-lipoxygenase at Ser-271 by MAPK-activated protein kinase 2 (MK2), J Biol Chem, 277, 14793, 10.1074/jbc.M111945200
Werz, 2002, Activation of 5-lipoxygenase by cell stress is calcium independent in human polymorphonuclear leukocytes, Blood, 99, 1044, 10.1182/blood.V99.3.1044
Bürkert, 2002, Hypertonicity suppresses ionophore-induced product formation and translocation of 5-lipoxygenase in human leukocytes, J Leukoc Biol, 71, 477, 10.1189/jlb.71.3.477
Bürkert, 2003, Cell type-dependent activation of 5-lipoxygenase by arachidonic acid, J Leuk Biol, 73, 191, 10.1189/jlb.0702354
Fischer, 2003, Phosphorylation- and stimulus-dependent inhibition of cellular 5-lipoxygenase activity by nonredox-type inhibitors, FASEB J, 28, 28
Werz, 2001, Phorbol ester up-regulates capacities for nuclear translocation and phosphorylation of 5-lipoxygenase in Mono Mac 6 cells and human polymorphonuclear leukocytes, Blood, 97, 2487, 10.1182/blood.V97.8.2487
Flamand, 2002, Cyclic AMP-mediated inhibition of 5-lipoxygenase translocation and leukotriene biosynthesis in human neutrophils, Mol Pharmacol, 62, 250, 10.1124/mol.62.2.250
Surette, 1999, Activation of leukotriene synthesis in human neutrophils by exogenous arachidonic acid: inhibition by adenosine A(2a) receptor agonists and crucial role of autocrine activation by leukotriene B(4), Mol Pharmacol, 56, 1055, 10.1124/mol.56.5.1055
Boden, 2000, MEK-1/2 inhibition prevents 5-lipoxygenase translocation in N-formylpeptide-challenged human neutrophils, Int J Biochem Cell Biol, 32, 1069, 10.1016/S1357-2725(00)00049-2
Luo, 2003, Nuclear localization of 5-lipoxygenase as a determinant of leukotriene B4 synthetic capacity, Proc Natl Acad Sci USA, 6, 6
Luo, 2005, Phosphorylation by protein kinase a inhibits nuclear import of 5-lipoxygenase, J Biol Chem, 280, 40609, 10.1074/jbc.M507045200
Ham, 1983, Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils, Proc Natl Acad Sci USA, 80, 4349, 10.1073/pnas.80.14.4349
Flamand, 2006, Arachidonic acid regulates the translocation of 5-lipoxygenase to the nuclear membranes in human neutrophils, J Biol Chem, 281, 129, 10.1074/jbc.M506513200
Rouzer, 1990, MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes, J Biol Chem, 265, 1436, 10.1016/S0021-9258(19)40034-3
Miller, 1990, Identification and isolation of a membrane protein necessary for leukotriene production, Nature, 343, 278, 10.1038/343278a0
Dixon, 1990, Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis, Nature, 343, 282, 10.1038/343282a0
Petersgolden, 1993, Redistribution of 5-lipoxygenase and cytosolic phospholipase-A2 to the nuclear fraction upon macrophage activation, Biochem Biophys Res Commun, 196, 147, 10.1006/bbrc.1993.2227
Woods, 1993, 5-Lipoxygenase and 5-lipoxygenase activating protein are localized in the nuclear envelope of activated human leukocytes, J Exp Med, 178, 1935, 10.1084/jem.178.6.1935
Woods, 1995, 5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation, J Clin Invest, 95, 2035, 10.1172/JCI117889
Brock, 1995, Translocation and leukotriene synthetic capacity of nuclear 5-lipoxygenase in rat basophilic leukemia cells and alveolar macrophages, J Biol Chem, 270, 21652, 10.1074/jbc.270.37.21652
Pouliot, 1996, Colocalization of cytosolic phospholipase A(2), 5-lipoxygenase, and 5-lipoxygenase-activating protein at the nuclear membrane of A23187-stimulated human neutrophils, Eur J Biochem, 238, 250, 10.1111/j.1432-1033.1996.0250q.x
Coffey, 1992, Membrane association of active 5-lipoxygenase in resting cells—evidence for novel regulation of the enzyme in the rat alveolar macrophage, J Biol Chem, 267, 570, 10.1016/S0021-9258(18)48532-8
Kargman, 1992, A23187-induced translocation of 5-lipoxygenase in osteosarcoma cells, J Cell Biol, 119, 1701, 10.1083/jcb.119.6.1701
Hatzelmann, 1993, Mode of action of the new selective leukotriene synthesis inhibitor BAY X-1005 ((R)-2-<4-(quinolin-2-yl-methoxy)phenyl>-2-cyclopentyl acetic acid) and structurally related compounds, Biochem Pharmacol, 45, 101, 10.1016/0006-2952(93)90382-7
Brock, 1998, Capacity for repeatable leukotriene generation after transient stimulation of mast cells and macrophages, Biochem J, 329, 519, 10.1042/bj3290519
Mancini, 1993, 5-Lipoxygenase-activating protein is an arachidonate binding protein, FEBS Lett, 318, 277, 10.1016/0014-5793(93)80528-3
Hatzelmann, 1994, Inversely-correlated inhibition of human 5-lipoxygenase activity by BAY X1005 and other quinoline derivatives in intact cells and a cell-free system—implications for the function of 5-lipoxygenase activating protein, Biochem Pharmacol, 47, 2259, 10.1016/0006-2952(94)90264-X
Charleson, 1994, Structural requirements for the binding of fatty acids to 5-lipoxygenase-activating protein, Eur J Pharmacol-Mol Pharm, 267, 275, 10.1016/0922-4106(94)90151-1
Abramovitz, 1993, 5-Lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase, Eur J Biochem, 215, 105, 10.1111/j.1432-1033.1993.tb18012.x
Mancini, 1998, Cellular oxygenation of 12-hydroxyeicosatetraenoic acid and 15-hydroxyeicosatetraenoic acid by 5-lipoxygenase is stimulated by 5-lipoxygenase-activating protein, J Biol Chem, 273, 32842, 10.1074/jbc.273.49.32842
Plante, 2006, 5-Lipoxygenase activating protein homodimer in human neutrophils. Evidence for a role in leukotriene synthesis, Biochem J, 393, 211, 10.1042/BJ20060669
Brock, 1994, Localization of 5-lipoxygenase to the nucleus of unstimulated rat basophilic leukemia cells, J Biol Chem, 269, 22059, 10.1016/S0021-9258(17)31755-6
Brock, 1997, Rapid import of cytosolic 5-lipoxygenase into the nucleus of neutrophils after in vivo recruitment and in vitro adherence, J Biol Chem, 272, 8276, 10.1074/jbc.272.13.8276
Spanbroek, 2003, Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis, Proc Natl Acad Sci USA, 100, 1238, 10.1073/pnas.242716099
Luo, 2004, Multiple nuclear localization sequences allow modulation of 5-lipoxygenase nuclear import, Traffic, 5, 847, 10.1111/j.1600-0854.2004.00227.x
Chen, 1998, Determinants of 5-lipoxygenase nuclear localization using green fluorescent protein 5-lipoxygenase fusion proteins, J Biol Chem, 273, 31237, 10.1074/jbc.273.47.31237
Healy, 1999, Identification of a bipartite nuclear localization sequence necessary for nuclear import of 5-lipoxygenase, J Biol Chem, 274, 29812, 10.1074/jbc.274.42.29812
Hanaka, 2002, Nuclear-localization-dependent and nuclear-export-signal-dependent mechanisms determine the localization of 5-lipoxygenase, Biochem J, 361, 505, 10.1042/0264-6021:3610505
Jones, 2002, Structural and functional criteria reveal a new nuclear import sequences on the 5-lipoxygenase protein, J Biol Chem, 277, 38550, 10.1074/jbc.M206070200
Jones, 2003, Identification of two novel nuclear import sequences on the 5-lipoxygenase protein, J Biol Chem, 278, 10257, 10.1074/jbc.M211021200
Cipollone, 2005, Association between 5-lipoxygenase expression and plaque instability in humans, Arterioscler Thromb Vasc Biol, 25, 1665, 10.1161/01.ATV.0000172632.96987.2d
Mehrabian, 2001, Genetic locus in mice that blocks development of atherosclerosis despite extreme hyperlipidemia, Circ Res, 89, 125, 10.1161/hh1401.093458
Mehrabian, 2002, Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice, Circ Res, 91, 120, 10.1161/01.RES.0000028008.99774.7F
Zhao, 2004, The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm, Nat Med, 10, 966, 10.1038/nm1099
Kuhn, 2003, Amino acid differences in the deduced 5-lipoxygenase sequence of CAST atherosclerosis-resistance mice confer impaired activity when introduced into the human ortholog, Arterioscler Thromb Vasc Biol, 1, 1
Shimizu, 1984, Enzyme with dual lipoxygenase activities catalyzes leukotriene A4 synthesis from arachidonic acid, Proc Natl Acad Sci USA, 81, 689, 10.1073/pnas.81.3.689
Toda, 2002, Leukotriene B4 receptors, Prostaglandins other lipid Mediat, 68–69, 575, 10.1016/S0090-6980(02)00056-4
Aiello, 2002, Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice, Arterioscler Thromb Vasc Biol, 22, 443, 10.1161/hq0302.105593
Bray, 1981, Leukotriene B4: biosynthesis and biological activities, 253
Datta, 1995, Peptido-leukotrienes are potent agonists of von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells, Circulation, 92, 3304, 10.1161/01.CIR.92.11.3304
Eriksson, 2001, Importance of primary capture and l-selectin-dependent secondary capture in leukocyte accumulation in inflammation and atherosclerosis in vivo, J Exp Med, 194, 205, 10.1084/jem.194.2.205
Subbarao, 2004, Role of leukotriene B4 receptors in the development of atherosclerosis: potential mechanisms, Arterioscler Thromb Vasc Biol, 24, 369, 10.1161/01.ATV.0000110503.16605.15
Heller, 2005, Inhibition of atherogenesis in BLT1-deficient mice reveals a role for LTB4 and BLT1 in smooth muscle cell recruitment, Circulation, 112, 578, 10.1161/CIRCULATIONAHA.105.545616
Back, 2005, Leukotriene B4 signaling through NF-κB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia, Proc Natl Acad Sci USA, 102, 17501, 10.1073/pnas.0505845102
Matsukawa, 1999, Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: cross-talk between MCP-1 and leukotriene B4, J Immunol, 163, 6148, 10.4049/jimmunol.163.11.6148
Huang, 2004, Leukotriene B4 strongly increases monocyte chemoattractant protein-1 in human monocytes., Arterioscler Thromb Vasc Biol, 24, 1783, 10.1161/01.ATV.0000140063.06341.09
Lotzer, 2003, Differential leukotriene receptor expression and calcium responses in endothelial cells and macrophages indicate 5-lipoxygenase-dependent circuits of inflammation and atherogenesis, Arterioscler Thromb Vasc Biol, 23, 32, 10.1161/01.ATV.0000082690.23131.CB
Sjostrom, 2003, Dominant expression of the CysLT2 receptor accounts for calcium signaling by cysteinyl leukotrienes in human umbilical vein endothelial cells, Arterioscler Thromb Vasc Biol, 23, 271, 10.1161/01.ATV.0000082689.46538.DF
Helgadottir, 2004, The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke., Nat Genet, 36, 233, 10.1038/ng1311
Helgadottir, 2005, Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population, Am J Hum Genet, 76, 505, 10.1086/428066
Lohmussaar, 2005, ALOX5AP gene and the PDE4D gene in a central European population of stroke patients, Stroke, 36, 731, 10.1161/01.STR.0000157587.59821.87
Hakonarson, 2005, Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial, JAMA, 293, 2245, 10.1001/jama.293.18.2245
Helgadottir, 2005, A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction, Nat Genet, 38, 68, 10.1038/ng1692
Funk, 1989, Characterization of the human 5-lipoxygenase gene, Proc Natl Acad Sci USA, 86, 2587, 10.1073/pnas.86.8.2587
Hoshiko, 1990, Characterization of the human 5-lipoxygenase gene promoter, Proc Natl Acad Sci USA, 87, 9073, 10.1073/pnas.87.23.9073
In, 1997, Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription, J Clin Invest, 99, 1130, 10.1172/JCI119241
Silverman, 1998, Egr-1 and Sp1 interact functionally with the 5-lipoxygenase promoter and its naturally occurring mutants, Am J Respir Cell Mol Biol, 19, 316, 10.1165/ajrcmb.19.2.3154
Dishart, 2005, GC-rich sequences in the 5-lipoxygenase gene promoter are required for expression in Mono Mac 6 cells, characterization of a novel Sp1 binding site, Biochim Biophys Acta, 1738, 37, 10.1016/j.bbalip.2005.11.008
Dwyer, 2004, Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis, N Engl J Med, 350, 29, 10.1056/NEJMoa025079
Drazen, 1999, Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment, Nat Genet, 22, 168, 10.1038/9680
Serhan, 2002, Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution, Prostaglandins Other Lipid Mediat, 68–69, 433, 10.1016/S0090-6980(02)00047-3
Powell, 2005, Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETE, Prog Lipid Res, 44, 154, 10.1016/j.plipres.2005.04.002